XML 35 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Option Activity

A summary of option activity under the 2019 Plan, 2024 Plan and the Inducement Plan is as follows:

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Weighted-
Average
Remaining
Contractual
Term (in
years)

 

 

Aggregate
Intrinsic
Value
(in
thousands)

 

Outstanding at December 31, 2024

 

 

7,595,922

 

 

$

5.83

 

 

 

7.58

 

 

$

760

 

Options granted

 

 

687,679

 

 

$

3.08

 

 

 

 

 

 

 

Options exercised

 

 

(3,955

)

 

$

0.73

 

 

 

 

 

 

 

Options forfeited

 

 

(250,766

)

 

$

5.77

 

 

 

 

 

 

 

Options expired

 

 

(49,070

)

 

$

4.64

 

 

 

 

 

 

 

Outstanding at March 31, 2025

 

 

7,979,810

 

 

$

5.60

 

 

 

7.44

 

 

$

30

 

Exercisable at March 31, 2025*

 

 

1,813,209

 

 

$

4.54

 

 

 

4.46

 

 

$

30

 

Vested and expected to vest at March 31, 2025

 

 

7,979,810

 

 

$

5.60

 

 

 

7.44

 

 

$

30

 

* Includes 186,769 shares of unvested stock options for which the holders have the right to early exercise such options as of March 31, 2025.

Summary of Restricted Stock Units

 

 

Number of RSUs

 

 

Weighted-
Average
Grant Rate Fair Value

 

Unvested at December 31, 2024

 

 

549,001

 

 

$

7.19

 

Granted - RSUs

 

 

112,000

 

 

 

2.70

 

Forfeited - RSUs

 

 

(25,834

)

 

 

6.88

 

Unvested at March 31, 2025

 

 

635,167

 

 

$

6.41

 

Schedule of Fair Value of Options Granted to Employees and Nonemployees Estimated using Black-Scholes Valuation Model using the Assumptions

The fair value of options granted was estimated using the Black-Scholes valuation model using the following assumptions for the three months ended March 31, 2025 and 2024, respectively:

 

 

 

Three Months Ended March 31,

 

 

2025

 

2024

Expected volatility

 

96.0% - 97.1%

 

93.0%

Expected dividend yield

 

0%

 

0%

Expected term (in years)

 

5.35 - 6.08

 

6.07 - 6.08

Risk-free interest rate

 

4.0% - 4.5%

 

4.1% - 4.2%

Schedule of Stock-based Compensation Expense

The following table presents the classification of stock-based compensation expense related to stock options granted (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

806

 

 

$

581

 

General and administrative

 

 

1,355

 

 

 

1,697

 

Total stock-based compensation expense

 

$

2,161

 

 

$

2,278